RBR-5y5sm9招募中2 期
Placebo-controled, randomized clinical trial to assess the active drug response (beta-2 adrenergic agonist) in the treatment of fatigue in patients with Multiple Sclerosis
Hospital de Clínicas da Universidade Federal do Paraná0 个研究点开始时间: 2019年1月8日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 69Y（—）
入选标准
- •Diagnosis of Multiple Sclerosis (according to McDonald's 2010 criteria); age between 18 and 70 years old; Expanded Disability Status Scale score (EDSS) up to 5.5; fatigue confirmed by Neurological Fatigue Index for Multiple Sclerosis validated for Brazil (NFI-MS/BR) and Fatigue Severity Scale (FSS)
排除标准
- •Multiple sclerosis relapse within 30 days prior to the study; poorly controlled hypothyroidism despite of treatment; any tachyarrhythmia identified on the electrocardiogram (ECG); decompensation of chronic systemic or psychiatric diseases (such as arterial hypertension, renal and hepatic impairment, and diabetes); pregnancy or lactation; not signing the consent term.
研究者
相似试验
尚未招募
2 期
Clinical trial of NRL/WW/19-20 to promote health and wellbeing in womaCTRI/2020/06/025639etsurf Communications Pvt Ltd
已完成
2 期
Clinical trial of plant sterol supplementation in hypercholesterolemia.CTRI/2021/08/035421Matrix fine Sciences Pvt Ltd90
已完成
2 期
Efficacy of amaranthus extract on male pattern hair lossCTRI/2022/07/043774Arjuna Natural Pvt Ltd50
尚未招募
2 期
To see the effect of Trikatu churna and life style modification in Sthaulya(obesity)CTRI/2019/04/018813ational Institute Of Ayurveda
进行中（未招募）
1 期
Randomised, placebo controlled clinical trial to evaluate remifentanil as maternal sedation and fetal immobilisation during diagnostic prenatal MRI.EUCTR2009-011281-28-BEniversity Hospitals Leuven50